Filing Details
- Accession Number:
- 0001161697-24-000492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-29 20:09:20
- Reporting Period:
- 2024-11-27
- Accepted Time:
- 2024-11-29 20:09:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1279473 | Gary Ingenito | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Chief Med. & Reg. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-11-27 | 12,000 | $4.01 | 63,391 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-11-27 | 8,631 | $22.74 | 54,760 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2024-11-27 | 3,369 | $22.67 | 51,391 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2024-11-27 | 12,000 | $0.00 | 12,000 | $4.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,041,631 | 2025-01-02 | No | 4 | M | Direct |
Footnotes
- Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- Options vested in three annual tranches beginning on January 2, 2019.
Billionaire Hedge Funds
